Skip to main content
. 2025 Jan 4;13:1. doi: 10.1186/s40478-024-01909-6

Fig. 2.

Fig. 2

Manhattan and QQ plots of SNP-based and Gene-Based genome-wide association results of neuropathological features of AD (n = 6960). Dotted red lines represent the threshold for genome-wide significance (P < 5 × 10−8) and Bonferroni correction for the gene-based analyses. A Neuropathologically-confirmed AD case–control GWAS. B Gene-based analysis for neuropathologically confirmed AD case–control sample. C Braak stage GWAS. D Gene-based analysis for Braak stage. E NP score GWAS. F Gene-based analysis for NP score